Business Context and Reporting Period
This Form 8-K Current Report was filed by Second Sight Medical Products, Inc. on August 28, 2018. The filing discloses the appointment of Patrick Ryan as Chief Operating Officer (COO), a newly created position, with an effective start date of September 1, 2018.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation terms:
- Annual Salary: $310,000
- Target Bonus: Up to 35% of annual salary
- Signing Bonus: $60,000 (subject to clawback provisions)
- Equity Grant: Option to purchase 500,000 shares at $1.69 per share
- Severance: 12 months of salary plus target bonus and COBRA coverage if terminated without cause
Material Changes
The primary material change is the expansion of the executive leadership team with the addition of a Chief Operating Officer. No financial or operational changes relative to prior periods are disclosed in this report.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of general business risks. The only contingencies noted relate to the employment agreement:
- Clawback Risk: The $60,000 signing bonus must be repaid in full if Mr. Ryan voluntarily leaves before August 31, 2019, or 50% if he leaves before August 31, 2020.
- Termination Terms: Employment is at-will; severance is only guaranteed if the Company terminates without cause.
Investor Verification Checklist
- Verify the vesting schedule of the 500,000 stock options (25% at one year, then quarterly).
- Confirm the specific performance metrics required to earn the 35% annual bonus.
- Review the full Executive Employment Agreement (Exhibit 10.1) for detailed definitions of "cause" and "without cause."
- Check subsequent filings for any updates on the Company's cash position to ensure it can support the new executive compensation package.